Clinical trials
Withdrawn Phase 2 Lung Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
54 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 2 |
| 2012 | 3 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 4 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 6 |
| 2023 | 4 |
| 2024 | 6 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 54 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 4 |
| M.D. Anderson Cancer Center | 3 |
| National Cancer Institute (NCI) | 3 |
| Alliance for Clinical Trials in Oncology | 2 |
| Eli Lilly and Company | 2 |
| Masonic Cancer Center, University of Minnesota | 2 |
| Novartis Pharmaceuticals | 2 |
| SWOG Cancer Research Network | 2 |
| University of Washington | 2 |
| Bristol-Myers Squibb | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 54 |
| Carcinoma, Non-Small-Cell Lung | 25 |
| Breast Neoplasms | 4 |
| Neoplasm Metastasis | 4 |
| Adenocarcinoma of Lung | 3 |
| Small Cell Lung Carcinoma | 3 |
| Brain Neoplasms | 2 |
| Head and Neck Neoplasms | 2 |
| Stomach Neoplasms | 2 |
| Anthrax | 1 |
Trials
Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.